Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Impaired Physical Function”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07694843
What this trial is testing

A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function

Who this might be right for
Healthy ParticipantsParticipants With Mild Hepatic ImpairmentParticipants With Moderate Hepatic Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 24
Not applicableWithdrawnNCT05108363
What this trial is testing

Effect of Obstructive Sleep Apnea on Glucose Control and Cognitive Function

Who this might be right for
Cognitive Change
Chinese University of Hong Kong
Not applicableUnknownNCT03821285
What this trial is testing

Respiratory Function in Patients With Post-tuberculosis Lung Impairment

Who this might be right for
Lung Diseases, ObstructivePulmonary RehabilitationLung TB
Università degli Studi dell'Insubria 100
Early research (Phase 1)Study completedNCT04831944
What this trial is testing

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

Who this might be right for
Advanced Malignancies
Incyte Corporation 21
Not applicableUnknownNCT01529658
What this trial is testing

Renal Hypothermia During Partial Nephrectomy

Who this might be right for
Renal ImpairmentKidney DiseasesUrologic Diseases+3 more
Ottawa Hospital Research Institute 184
Not applicableLooking for participantsNCT05460143
What this trial is testing

Optical Neuroimaging and Cognition

Who this might be right for
Dementia With Lewy BodiesAlzheimer DiseaseMild Cognitive Impairment
University of Cambridge 200
Not applicableStudy completedNCT00893815
What this trial is testing

Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients

Who this might be right for
HIV InfectionsMemory
Henry M. Jackson Foundation for the Advancement of Military Medicine 250
Not applicableActive Not RecruitingNCT01176578
What this trial is testing

Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Baltimore VA Medical Center 70
Not applicableLooking for participantsNCT07369648
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for Motor Recovery After Ischemic Stroke (rTMS-MOTOR)

Who this might be right for
Ischemic StrokeHemiplegiaMotor Function Impairment
Hanoi Medical University 66
Early research (Phase 1)Study completedNCT02436447
What this trial is testing

Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function

Who this might be right for
Normal and Impaired Renal Function
Stealth BioTherapeutics Inc. 23
Early research (Phase 1)Study completedNCT05917938
What this trial is testing

A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Novo Nordisk A/S 33
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Ended earlyNCT01278758
What this trial is testing

A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function

Who this might be right for
Metastatic Cancer
Novartis Pharmaceuticals 7
Early research (Phase 1)Study completedNCT00833716
What this trial is testing

Effect of Renal Impairment on the Pharmacokinetics of NN9535

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Renal Impairment
Novo Nordisk A/S 62
Early research (Phase 1)Ended earlyNCT01278849
What this trial is testing

An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function

Who this might be right for
Histologically-proven and Radiologically-confirmed Solid Tumors
Novartis Pharmaceuticals 5
Early research (Phase 1)Study completedNCT05005312
What this trial is testing

Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332

Who this might be right for
Hepatic Impairment
Pfizer 17
Early research (Phase 1)Study completedNCT06692322
What this trial is testing

Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 29
Early research (Phase 1)Study completedNCT03776539
What this trial is testing

Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02

Who this might be right for
Impaired Renal Function
Eloxx Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Looking for participantsNCT07422857
What this trial is testing

Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

Who this might be right for
Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia
JYAMS PET Research & Development Limited 316
Early research (Phase 1)Study completedNCT02808312
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)
Gilead Sciences 57
Next Page